Socioeconomic and Geographic Disparities in Idiopathic Intracranial Hypertension
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 7, 2020
- Accepted in final form March 8, 2021
- First Published May 12, 2021.
Article Versions
- Previous version (May 12, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Venkatesh L. Brahma, MD,
- Jonathan Snow, BS,
- Vicky Tam, MA,
- Ahmara G. Ross, MD, PhD,
- Madhura A. Tamhankar, MD,
- Kenneth S. Shindler, MD, PhD,
- Robert A. Avery, DO, MSCE,
- Grant T. Liu, MD and
- Ali G. Hamedani, MD, MHS
- Venkatesh L. Brahma, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Jonathan Snow, BS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vicky Tam, MA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ahmara G. Ross, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Madhura A. Tamhankar, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kenneth S. Shindler, MD, PhD,
(1) Noveome Biotherapeutics, Inc
NONE
(1) Santen, Inc.
(1) Journal of Neuro-Ophthalmology (2) Frontiers in Neurology
(1) Gene therapy vectors for treatment of optic neuropathies
(1) Tolosa Hunt Syndrome, UpToDate, Inc., 2005-2021
NONE
(1) Noveome Biotherapeutics, Inc.
NONE
NONE
NONE
(1) Gyroscope Therapeutics, Inc. (2) Mallinckrodt Pharmaceuticals, Inc (3) Noveome Biotherapeutics, Inc.
(1) NIH EY019014, PI, 2010-2021
NONE
(1) Research to Prevent Blindness (2) F.M. Kirby Foundation
NONE
NONE
NONE
NONE
NONE
(10 expert witness for defense or plaintiff in various legal cases
- Robert A. Avery, DO, MSCE,
NONE
NONE
NONE
Neuropediatrics, Associate editor, 2012-present
NONE
NONE
NONE
1. Consultant for Takeda Pharmaceuticals.
NONE
NONE
NONE
NONE
1. NIH EY029687, PI, 2019-present 2. NIH 3U10CA180886-04S1, supplement PI, 2019-present 3. NIH 1UG3CA236536, PI, 2020-present 4. US DOD W81XWH19-1-0376, PI, 2019-present
NONE
Children's Tumor Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Grant T. Liu, MD and
NONE
NONE
NONE
NONE
NONE
Liu, Volpe, Galetta's Neuro-ophthalmology, 2019, Elsevier
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ali G. Hamedani, MD, MHS
NONE
NONE
1. Parkinson Study Group, honoraria for grant peer review 2. Northwell Health, honoraria for speaking engagement
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NINDS T32 NS061779-10 (2018-2020)
NONE
Parkinson Study Group Mentored Clinical Research Award (2019-2020)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Division of Neuro-ophthalmology, Departments of Neurology and Ophthalmology (V.L.B., A.G.R., M.A.T., K.S.S., R.A.A., G.T.L.), Division of Neuro-ophthalmology, Department of Neurology (A.G.H.), and Translational Center of Excellence for Neuroepidemiology and Neurology Outcomes Research (A.G.H.), Perelman School of Medicine (J.S.), Center for Clinical Epidemiology and Biostatistics (V.T., A.G.H.), University of Pennsylvania, Philadelphia.
- Correspondence
Dr. Brahma vbrahma414{at}gmail.com
Article usage
Cited By...
Letters: Rapid online correspondence
- Reader Response: Socioeconomic and Geographic Disparities in Idiopathic Intracranial Hypertension
- Abigail L Bishop, Graduate Student, University of Wisconsin - Madison
Submitted December 12, 2021
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Incidence, Prevalence, and Health Care Outcomes in Idiopathic Intracranial HypertensionA Population StudyLatif Miah, Huw Strafford, Beata Fonferko-Shadrach et al.Neurology, January 20, 2021 -
Review
The Potentially Modifiable Risk Factor in Idiopathic Intracranial HypertensionBody WeightSusan P. Mollan, Abd A. Tahrani, Alexandra J. Sinclair et al.Neurology: Clinical Practice, March 03, 2021 -
Articles
Racial differences in idiopathic intracranial hypertensionB. B. Bruce, P. Preechawat, N. J. Newman et al.Neurology, March 10, 2008 -
Article
Neighborhood socioeconomic disadvantage and mortality after strokeArleen F. Brown, Li-Jung Liang, Stefanie D. Vassar et al.Neurology, January 02, 2013